Excipients

(Image: Getty/Bedo)

The most read stories in March

By Staff Reporter

After the M&A excitement that began the year, the developments in March were a mixture of long-running events, such as the sartan manufacturing issues, breakthrough research and regulatory struggles.

Chinese excipient market set to more than double by 2017

Chinese excipient market set to more than double by 2017

By Zachary Brennan

With more than 90 excipient manufacturers in China dedicated to the pharma industry, the country expects its output of excipients to more than double to about $8.9bn (€7.1bn), according to a new report.

EU revives GMP for excipients

EU revives GMP for excipients

By Nick Taylor

The EFCG has welcomed the addition of excipient GMP requirements to the draft amendments of the EU falsified medicines directive but warned that deeper analysis is needed to establish which products warrant further regulation.